Cyrus Biotechnology, Inc. Sustainability Profile
Cyrus Biotechnology, Inc., commonly referred to as Cyrus Bio, is a pioneering company headquartered in the United States, with significant operations across various regions. Founded in 2014, Cyrus Bio operates at the intersection of biotechnology and computational science, specialising in protein design and engineering. The company is renowned for its innovative software solutions, particularly the Cyrus Bench platform, which streamlines the process of protein design, making it accessible and efficient for researchers and biopharmaceutical companies. With a strong focus on enhancing drug development and therapeutic applications, Cyrus Bio has established itself as a leader in the biotech industry, recognised for its unique approach to computational protein design. Through its commitment to advancing biotechnological research, Cyrus Bio continues to achieve notable milestones, solidifying its position as a key player in the evolving landscape of biotechnology.
DitchCarbon Score
How does Cyrus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cyrus Biotechnology, Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cyrus Biotechnology, Inc.'s reported carbon emissions
In 2023, Cyrus Biotechnology, Inc. reported no specific carbon emissions data, indicating a total of 0 kg CO2e across all scopes. The company has not disclosed any Scope 1, 2, or 3 emissions figures, nor has it set any reduction targets or initiatives related to carbon emissions. Cyrus Biotechnology's climate commitments remain unspecified, and there are no cascading emissions data from a parent or related organisation. The absence of emissions data suggests a potential focus on sustainability practices, but without concrete figures or targets, the company's climate impact remains unclear. As the organisation continues to develop its environmental strategies, further transparency regarding emissions and commitments will be essential for stakeholders and the broader industry context.
How Carbon Intensive is Cyrus Biotechnology, Inc.'s Industry?
How Carbon Intensive is Cyrus Biotechnology, Inc.'s Location?
Cyrus Biotechnology, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cyrus Biotechnology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.